K

KalVista Pharmaceuticals, Inc.

107 employees

KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME).

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Diabetes
Health Care

Date founded

2011

Funding rounds raised

Total raised

$33M

from 7 investors over 7 rounds

K

KalVista Pharmaceuticals, Inc. raised $33M on July 22, 2015

Investors: Novo Holdings, Longwood Fund, SV Life Sciences, Venrock and RA Capital Management, L.P.

K

KalVista Pharmaceuticals, Inc. raised $13M on August 23, 2011

Investors: SV Life Sciences and Novo Holdings

FAQ